These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 4605071)

  • 1. Rifampicin plus isoniazid, rifampicin plus PAS, and isoniazid plus PAS in the initial treatment of pulmonary tuberculosis. A controlled multicenter clinical trial.
    Tousek J; Votruba R
    Chemotherapy; 1974; 20(3):183-200. PubMed ID: 4605071
    [No Abstract]   [Full Text] [Related]  

  • 2. Rifampin-isoniazid compared with PAS-isoniazid-streptomycin in initial treatment of pulmonary tuberculosis. A controlled cooperative trial.
    Boman G
    Chest; 1972 Jun; 61(6):533-8. PubMed ID: 5032151
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical evaluation of Rifampicin in pulmonary tuberculosis. 2. A controlled trial on the clinical effects of chemotherapy with Rifampicin-INH-PAS and SM-INH-PAS for treatment of original cases of pulmonary tuberculosis].
    Donomae I; Fujita S; Gomi J; Hibino S; Horai Z
    Kekkaku; 1970 Aug; 45(8):257-62. PubMed ID: 4918166
    [No Abstract]   [Full Text] [Related]  

  • 4. Rifampin in initial treatment of pulmonary tuberculosis. A.U.S. Public Health Service tuberculosis therapy trial.
    Newman R; Doster BE; Murray FJ; Woolpert SF
    Am Rev Respir Dis; 1974 Feb; 109(2):216-32. PubMed ID: 4204541
    [No Abstract]   [Full Text] [Related]  

  • 5. The antituberculosis efficacy of rifampin in 136 patients.
    Davidson PT; Goble M; Lester W
    Chest; 1972 Jun; 61(6):574-8. PubMed ID: 4624279
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
    Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
    [No Abstract]   [Full Text] [Related]  

  • 7. Co-operative controlled trial of a standard regimen of streptomycin, PAS and isoniazid and three alternative regimens of chemotherapy in Britain. A report from the British Medical Research Council.
    Tubercle; 1973 Jun; 54(2):99-129. PubMed ID: 4203162
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum enzyme changes in patients receiving antituberculosis therapy with rifampicin or p-aminosalicylic acid, plus isoniazid and streptomycin.
    Baron DN; Bell JL
    Tubercle; 1974 Jun; 55(2):115-20. PubMed ID: 4620296
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparison of three regimens, INH-SM-PAS, INH-SM-RFP and INH-PAS-RFP, in the original treatment cases of pulmonary tuberculosis. Report of the 13th series study (original treatment study)].
    Kekkaku; 1973 Jun; 48(6):235-45. PubMed ID: 4581528
    [No Abstract]   [Full Text] [Related]  

  • 10. Controlled trial of intermittent regimens of rifampicin plus isoniazid for pulmonary tuberculosis in Singapore.
    Lancet; 1975 Dec; 2(7945):1105-9. PubMed ID: 53598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled comparison of oral twice-weekly and oral daily isoniazid plus PAS in newly diagnosed pulmonary tuberculosis.
    Br Med J; 1973 Apr; 2(5857):7-11. PubMed ID: 4633061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial treatment of tuberculosis with rifampicin.
    O'Connell J; Campbell AH; Cowen K; Verins A
    Med J Aust; 1973 Nov; 2(19):881-5. PubMed ID: 4765873
    [No Abstract]   [Full Text] [Related]  

  • 13. Intermittent therapy with rifampin once a week in advanced pulmonary tuberculosis.
    Verbist L; Mbete S; Van Landuyt H; Darras T; Gyselen A
    Chest; 1972 Jun; 61(6):555-63. PubMed ID: 4624278
    [No Abstract]   [Full Text] [Related]  

  • 14. A four-year follow-up of patients with quiescent pulmonary tuberculosis at the end of a year of chemotherapy with twice-weekly isoniazid plus streptomycin or daily isoniazid plus pas.
    Ramakrishnan CV; Devadatta S; Evans C; Fox W; Menon NK; Nazareth O; Radhakrishna S; Sambamoorthy S; Stott H; Tripathy SP; Velu S
    Tubercle; 1969 Jun; 50(2):115-24. PubMed ID: 4892322
    [No Abstract]   [Full Text] [Related]  

  • 15. Rifampin therapy of pulmonary tuberculosis in patients not treated previously with antituberculous drugs.
    Eidus L; Jessamine AG; Helbaque DM; Narasimhan V
    Int J Clin Pharmacol; 1974 Jan; 9(1):81-6. PubMed ID: 4593132
    [No Abstract]   [Full Text] [Related]  

  • 16. Isoniazid plus rifampicin in the initial treatment of pulmonary tuberculosis.
    Clarke GB; Cuthbert J; Cuthbert RJ; Lees AW
    Br J Dis Chest; 1972 Oct; 66(4):268-71. PubMed ID: 5083434
    [No Abstract]   [Full Text] [Related]  

  • 17. Controlled therapeutic trial with the combination rifampicin-isoniazid given for six months to previously untreated patients with pulmonary tuberculosis.
    Dubra F
    Bull Int Union Tuberc; 1972 Feb; 47():37-40. PubMed ID: 4562016
    [No Abstract]   [Full Text] [Related]  

  • 18. [Place of bacteriological examination in the treatment of tuberculosis].
    Gyselen A
    Acta Tuberc Pneumol Belg; 1972; 63(4):405-8. PubMed ID: 4206438
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of single and divided daily dosages of isoniazid and PAS in the treatment of pulmonary tuberculosis. XV. A report of the Veterans Administration-Armed Forces Cooperative. Study on the chemotherapy of tuberculosis.
    Reisner D
    Am Rev Respir Dis; 1966 Dec; 94(6):849-57. PubMed ID: 4958797
    [No Abstract]   [Full Text] [Related]  

  • 20. Rifampin plus isoniazid in initial therapy of pulmonary tuberculosis and rifampin and ethambutol in retreatment cases.
    Lees AW; Allan GW; Smith J; Tyrell WF; Fallon RJ
    Chest; 1972 Jun; 61(6):579-82. PubMed ID: 4260668
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.